Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
8(40%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
9
45%
Ph phase_2
1
5%
Ph phase_1
3
15%
Ph phase_3
1
5%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
3(21.4%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
9(64.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

8

trials recruiting

Total Trials

20

all time

Status Distribution
Active(12)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

Recruiting6
Not yet recruiting4
unknown4
Completed3
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
8
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (21.4%)
Phase 21 (7.1%)
Phase 31 (7.1%)
N/A9 (64.3%)

Trials by Status

active_not_recruiting210%
not_yet_recruiting420%
completed315%
unknown420%
recruiting630%
terminated15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07550010Not Applicable

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Recruiting
NCT05129787Not Applicable

Ablation vs Resection of Colorectal Cancer Liver Metastases

Active Not Recruiting
NCT06815939Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Recruiting
NCT05431699Not Applicable

Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test

Active Not Recruiting
NCT03993678Phase 1

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Completed
NCT07237399

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

Not Yet Recruiting
NCT06609876Not Applicable

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

Recruiting
NCT06709586

Thermal Ablation Versus Parathyroidectomy for Secondary Hyperparathyroidism

Not Yet Recruiting
NCT06708871

Thermal Ablation Versus Parathyroidectomy for Primary Hyperparathyroidism

Not Yet Recruiting
NCT06610604

Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules

Recruiting
NCT06583057

Multicenter Comparison of Thermal Ablation Versus Thyroid Lobectomy for Subcapsular Papillary Thyroid Microcarcinoma

Completed
NCT05472311Not Applicable

Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation

Recruiting
NCT06326294Not Applicable

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Recruiting
NCT03088150Not Applicable

COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation

Unknown
NCT05611359Not Applicable

Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer

Not Yet Recruiting
NCT03864211Phase 1

Thermal Ablation Followed by Immunotherapy for HCC

Unknown
NCT01862718Phase 1

Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms

Terminated
NCT05495529

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Completed
NCT05240404Phase 2

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Unknown
NCT02630108Phase 3

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Unknown

All 20 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
20